Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • alembic pharma

    Tag: alembic pharma

    You Searched For "alembic pharma"
    Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension

    Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension

    Medical Dialogues Bureau25 Jan 2020 12:11 PM IST
    New Delhi: Alembic Pharmaceuticals (Alembic) on Friday said it has received final nod from US health regulator for Bosentan tablets, used for...
    Alembic Pharma gets two USFDA observations for Karkhadi facility

    Alembic Pharma gets two USFDA observations for Karkhadi facility

    Medical Dialogues Bureau21 Jan 2020 12:50 PM IST
    New Delhi: Drugs maker, Alembic Pharma recently announced that the company's API facility located at Karkhadi has received Form 483 with two...
    Alembic Pharma gets USFDA nod for spasticity drug Tizanidine

    Alembic Pharma gets USFDA nod for spasticity drug Tizanidine

    MD bureau15 Jan 2020 10:15 AM IST
    New Delhi: Drug firm Alembic Pharmaceuticals on Wednesday said it has received final nod from the US health regulator for Tizanidine hydrochloride...
    Alembic JV Aleor Derma gets USFDA nod for therapeutic equivalent of Clobex Spray

    Alembic JV Aleor Derma gets USFDA nod for therapeutic equivalent of Clobex Spray

    Farhat Nasim4 Oct 2019 12:40 PM IST
    Clobetasol Propionate Spray, 0.05% is indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA)...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    Alembic Pharma gets USFDA nod for generic version of Uloric tablets

    Alembic Pharma gets USFDA nod for generic version of Uloric tablets

    Farhat Nasim2 July 2019 11:49 AM IST
    The approved product, Febuxostat tablet is therapeutically equivalent to the reference listed drug Uloric tablets of Takeda Pharmaceuticals USA, Inc....
    Alembic Pharma gets USFDA nod for Clonazepam orally disintegrating tablets

    Alembic Pharma gets USFDA nod for Clonazepam orally disintegrating tablets

    Farhat Nasim1 July 2019 12:25 PM IST
    The approval from the United States Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Clonazepam...
    Alembic Pharma clears USFDA inspection at oncology unit in Panelav

    Alembic Pharma clears USFDA inspection at oncology unit in Panelav

    Farhat Nasim29 Jun 2019 10:02 AM IST
    This was a first scheduled inspection and Alembic Pharma passed the inspection without any Form 483 Observation.New Delhi: Alembic Pharmaceuticals...
    Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution

    Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution

    Farhat Nasim24 Jun 2019 12:25 PM IST
    The approved product, Bromfenac Ophthalmic Solution is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution,...
    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Farhat Nasim2 May 2019 4:04 PM IST
    Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
    Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution

    Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution

    Farhat Nasim22 April 2019 11:55 AM IST
    Teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis while Tobramycin ophthalmic solution is a...
    Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

    Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

    Farhat Nasim6 March 2019 9:45 AM IST
    The company's JV, Aleor Dermaceuticals Ltd, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok